CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Self-System Therapy for Older Adults with Advanced Lung Cancer (SST-LC)behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04057196
NCT04057196N/ACompleted
CompareCT.gov

Self-System Therapy for Older Adults With Advanced Lung Cancer (SST-LC)

Duke University·interventional·Posted Aug 15, 2019·Updated Aug 3, 2022

In Brief

A clinical study evaluating Self-System Therapy for Older Adults with Advanced Lung Cancer (SST-LC) for Lung Cancer Stage III and Lung Cancer Stage IV. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The purpose of this study to use Self-system therapy (SST), to treat depression and lung-cancer-related distress in older adults (65 years and older).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer Stage III, Lung Cancer Stage IV
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH)

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedAug 15, 2019
Enrollment StartApr 2, 2020
Primary CompletionMay 20, 2021
Study CompletionJun 24, 2021
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 6.9 years ago

Interventions

Self-System Therapy for Older Adults with Advanced Lung Cancer (SST-LC)behavioral

The SST-LC is a brief structured intervention deliverable by video conference. The new SST-LC protocol will incorporate behavioral strategies designed to meet the needs of older adults with lung cancer, including examining individual and shared expectations for lung cancer care, identifying discrepancies between expectations and realistic possibilities, and modifying stress-exacerbating behaviors.